Detalhe da pesquisa
1.
Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression.
J Biol Chem
; 300(4): 107146, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460939
2.
A Potent, Selective CBX2 Chromodomain Ligand and Its Cellular Activity During Prostate Cancer Neuroendocrine Differentiation.
Chembiochem
; 22(13): 2335-2344, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33950564
3.
Polycomb group proteins in cancer: multifaceted functions and strategies for modulation.
NAR Cancer
; 3(4): zcab039, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34617019
4.
Therapeutic inhibition of SGK1 suppresses colorectal cancer.
Exp Mol Med
; 49(11): e399, 2017 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29170478
5.
Therapeutic Suppression of miR-4261 Attenuates Colorectal Cancer by Targeting MCC.
Mol Ther Nucleic Acids
; 8: 36-45, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28918036
6.
Development of a new analog of SGK1 inhibitor and its evaluation as a therapeutic molecule of colorectal cancer.
J Cancer
; 8(12): 2256-2262, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28819428